UNSPSC 51292022: Diisopromine hydrochloride

This classification denotes an antispasmotic agent with the molecular formula C21H29N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9E8EN393AL, chemically known as n,n-diisopropyl-3,3-diphenylpropylamine hydrochloride but more generally known as diisopromine hydrochloride, which bears US NIH Compound Identifier 71910. European Medicines Agency schedules Diisopromine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01730MIG.

Most nations, for tariff and trade purposes, schedule diisopromine hydrochloride under HS 29214980. As of Q4 2014, DIISOPROMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Diisopromine hydrochloride bears US NLM identifiers UMLS ID C1880325 and NCI Concept Code C65388. SMILES: CC(C)N(CCC(C1CCCCC1)C2CCCCC2)C(C)C.CL.

UNSPSC 51292022 Diisopromine hydrochloride is a Commodity code that in practice does not align with recent state and local procurement activity. The three recent opportunities posted under or near this code — a Seminole County naloxone procurement, a Texas HHS Request for Information on direct-to-manufacturer prescriptions, and a Minnesota cooperative purchasing alliance RFP for generic multi-source pharmaceuticals and OTC products — involve naloxone, prescription fulfillment intermediation, and over-the-counter pharmaceutical distribution, none of which match diisopromine hydrochloride (a pharmaceutical compound with specific clinical applications distinct from opioid antagonists or general OTC products). The code shows little relevant recent activity in state and local contracting, and the opportunities tagged to it appear to reflect broad pharmaceutical-category tagging rather than procurement of this specific compound.

No state and local solicitations for diisopromine hydrochloride itself are evident in the recent-opportunities record. Buyers considering this code should verify whether their target jurisdictions actually use this UNSPSC designation for their pharmaceutical procurements, as the current tagging appears to conflate multiple distinct pharmaceutical categories. If diisopromine hydrochloride is actually being sourced by state or local health departments, correctional agencies, or other public health bodies, those opportunities are not surfacing under this code in recent postings.